Gillianne Lai

1.2k total citations
18 papers, 374 citations indexed

About

Gillianne Lai is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Gillianne Lai has authored 18 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Gillianne Lai's work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Gillianne Lai is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Gillianne Lai collaborates with scholars based in Singapore, United States and China. Gillianne Lai's co-authors include Alexander Drilon, Zishuo I. Hu, Daniel S.W. Tan, Daniel Shao-Weng Tan, Huihua Li, Alexandre Chan, Richard Quek, Miriam Tao, Soon Thye Lim and Wan‐Teck Lim and has published in prestigious journals such as Annals of Oncology, Nature Reviews Clinical Oncology and Fish & Shellfish Immunology.

In The Last Decade

Gillianne Lai

14 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillianne Lai Singapore	5	197	190	122	106	70	18	374
Samuel Suzuki United States	9	130 0.7×	228 1.2×	214 1.8×	102 1.0×	65 0.9×	22	460
Matteo Repetto Italy	10	126 0.6×	159 0.8×	131 1.1×	114 1.1×	40 0.6×	23	360
Mahtab Farzin Australia	10	271 1.4×	132 0.7×	86 0.7×	42 0.4×	81 1.2×	22	441
Sarah Abou Alaiwi United States	12	207 1.1×	238 1.3×	127 1.0×	92 0.9×	51 0.7×	44	428
P. Dieringer United States	7	158 0.8×	203 1.1×	299 2.5×	76 0.7×	37 0.5×	10	501
Eisei Shin Japan	12	121 0.6×	250 1.3×	127 1.0×	163 1.5×	79 1.1×	30	485
Amanda C. Pawlak United States	4	423 2.1×	339 1.8×	180 1.5×	144 1.4×	62 0.9×	5	576
Barbara Szostakiewicz Poland	7	233 1.2×	245 1.3×	151 1.2×	90 0.8×	37 0.5×	20	437
Bhumsuk Keam South Korea	9	134 0.7×	312 1.6×	98 0.8×	56 0.5×	72 1.0×	17	568
Farhat Ghaznawi United States	5	245 1.2×	224 1.2×	173 1.4×	170 1.6×	38 0.5×	10	437

Countries citing papers authored by Gillianne Lai

Since Specialization

Citations

This map shows the geographic impact of Gillianne Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillianne Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillianne Lai more than expected).

Fields of papers citing papers by Gillianne Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillianne Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillianne Lai. The network helps show where Gillianne Lai may publish in the future.

Co-authorship network of co-authors of Gillianne Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Gillianne Lai. A scholar is included among the top collaborators of Gillianne Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillianne Lai. Gillianne Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lai, Gillianne, et al.. (2025). Phenotypic and functional characterization of CD4-2+ T cells in large yellow croaker Larimichthys crocea. Fish & Shellfish Immunology. 165. 110560–110560.

Lai, Gillianne, Luyang Zhao, Wenxuan Zhang, et al.. (2025). Characterization of CD8+ T Cells in large yellow croaker Larimichthys crocea and their dynamics in response to Cryptocaryon irritans infection. Fish & Shellfish Immunology. 166. 110596–110596.

Saw, Stephanie P.L., Gillianne Lai, Landon L. Chan, et al.. (2024). Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC. Lung Cancer. 193. 107856–107856. 4 indexed citations

Lai, Gillianne & Daniel S.W. Tan. (2024). Lung cancer screening in never smokers. Current Opinion in Oncology. 37(1). 95–104. 2 indexed citations

Lai, Gillianne, Xin Cheng, Yvonne Ang, et al.. (2023). Molecular testing in non-small cell lung cancer: A consensus recommendation. Annals of the Academy of Medicine Singapore. 52(7). 364–373.

Tan, Wan Ling, Sze Huey Tan, Daniel S.W. Tan, et al.. (2023). EP12.01-31 Updated First-line Osimertinib in Asian patients with Advanced EGFR-mutated Lung Cancer. Journal of Thoracic Oncology. 18(11). S652–S653.

Saw, Stephanie P.L., Gek San Tan, Aaron C. Tan, et al.. (2023). Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure. JTO Clinical and Research Reports. 4(12). 100599–100599. 2 indexed citations

Wang, Lanying, Wan‐Teck Lim, Chee‐Keong Toh, et al.. (2023). Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer. Human Genomics. 17(1). 66–66. 7 indexed citations

Ma, Jun, Sze Huey Tan, Gek San Tan, et al.. (2023). Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance. Translational Lung Cancer Research. 12(4). 742–753. 3 indexed citations

10.

Chowdhury, Anirban, Mei‐Kim Ang, Daniel Shao-Weng Tan, et al.. (2023). The impact of multi-modality treatment in geriatric patients with unresectable Stage 3 NSCLC. Journal of Geriatric Oncology. 14(8). S18–S18. 1 indexed citations

11.

Yin, Xin, Gillianne Lai, Adeline Seow, et al.. (2022). Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes. Frontiers in Public Health. 10. 1079543–1079543. 4 indexed citations

12.

Tan, Wan Ling, Sze Huey Tan, Daniel Shao-Weng Tan, et al.. (2021). P76.46 First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer. Journal of Thoracic Oncology. 16(3). S607–S607. 1 indexed citations

13.

Wong, Evelyn, et al.. (2020). 1383P Lung cancer in adolescents and young adults (AYA) in Asia: Tumour characteristics and molecular profiles. Annals of Oncology. 31. S880–S880. 1 indexed citations

14.

Lai, Gillianne, et al.. (2020). Management of oncology-related emergencies at the emergency department: A long-term undertaking. Hong Kong Journal of Emergency Medicine. 30(6). 333–340. 1 indexed citations

15.

Lai, Gillianne, et al.. (2019). Management of Oncology-Related Emergencies at the Emergency Department (MORE-ED)—A Long-Term Undertaking. Journal of Emergency Medicine. 57(3). 423–423. 1 indexed citations

16.

Drilon, Alexander, Zishuo I. Hu, Gillianne Lai, & Daniel S.W. Tan. (2017). Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nature Reviews Clinical Oncology. 15(3). 151–167. 275 indexed citations

17.

Drilon, Alexander, Zishuo I. Hu, Gillianne Lai, & Daniel Shao-Weng Tan. (2017). Erratum: Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nature Reviews Clinical Oncology. 15(3). 150–150. 46 indexed citations

18.

Lai, Gillianne, Soon Thye Lim, Miriam Tao, et al.. (2009). Late‐onset neutropenia following RCHOP chemotherapy in diffuse large B‐cell lymphoma. American Journal of Hematology. 84(7). 414–417. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact